Regulation of endothelial signaling and migration by v-ATPase

Angiogenesis

Volumn 17, Issue 3, 2014, Pages 587-601

  Rath, Sebastian ^a   Liebl, Johanna ^a   Fürst, Robert ^a,b   Vollmar, Angelika M ^a   Zahler, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Concanamycin; Endothelial; HUVEC; v ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CONCANAMYCIN A; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOTCH RECEPTOR; PROTEIN KINASE B; RAC1 PROTEIN; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE; VASCULOTROPIN RECEPTOR 2; ATP6V0C PROTEIN, HUMAN; ENZYME INHIBITOR; MACROLIDE; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANGIOGENESIS; ARTICLE; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYSOSOME MEMBRANE; M PHASE CELL CYCLE CHECKPOINT; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL CYCLE; CELL DEATH; CELL MEMBRANE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE SILENCING; METABOLISM; PHOSPHORYLATION; PROTEIN SUBUNIT;

CELL ADHESION; CELL CYCLE; CELL DEATH; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GENE SILENCING; HUMANS; MACROLIDES; PHOSPHORYLATION; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-AKT; RAC1 GTP-BINDING PROTEIN; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; VACUOLAR PROTON-TRANSLOCATING ATPASES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84903902451     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9408-z     Document Type: Article

References (46)

1. Hinton A, Bond S, Forgac M (2009) V-ATPase functions in normal and disease processes. Pflugers Arch 457(3):589-598. doi: 10.1007/s00424-007-0382-4
2. Wada Y, Sun-Wada GH, Tabata H, Kawamura N (2008) Vacuolar-type proton ATPase as regulator of membrane dynamics in multicellular organisms. J Bioenerg Biomembr 40(1):53-57. doi: 10.1007/s10863-008-9128-z
3. Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8(11):917-929. doi: 10.1038/nrm2272
4. Marshansky V, Futai M (2008) The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol 20(4):415-426. doi: 10.1016/jceb200803015S0955-0674(08)00056-2
5. Li YP, Chen W, Liang YQ, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23(4):447-451. doi: 10.1038/70563
6. Kinashi H, Someno K, Sakaguchi K (1984) Isolation and characterization of concanamycins A B and C. J Antibiot (Tokyo) 37(11):1333-1343
7. Werner G, Hagenmaier H, Drautz H, Baumgartner A, Zahner H (1984) Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo) 37(2):110-117
8. Sennoune SR, Luo D, Martinez-Zaguilan R (2004) Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys 40(2):185-206
9. Huss M, Wieczorek H (2009) Inhibitors of V-ATPases: old and new players. J Exp Biol 212(Pt 3):341-346. doi: 10.1242/jeb.024067212/3/341
10. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674. doi: 10.1016/j.cell.2011.02.013S0092-8674(11)00127-9
11. Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767-777. doi: 10.1038/Nrd3554
12. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A (2009) V-ATPase inhibitors and implication in cancer treatment. Cancer Treat Rev 35(8):707-713. doi: 10.1016/jctrv200908003S0305-7372(09)00119-4
13. Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE, Gorelick F (2011) The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest 91(5):732-743. doi: 10.1038/labinvest.2011.8labinvest20118
14. Schoonderwoert VT, Holthuis JC, Tanaka S, Tooze SA, Martens GJ (2000) Inhibition of the vacuolar H+-ATPase perturbs the transport, sorting, processing and release of regulated secretory proteins. Eur J Biochem 267(17):5646-5654
15. Wiedmann RM, von Schwarzenberg K, Palamidessi A, Schreiner L, Kubisch R, Liebl J, Schempp C, Trauner D, Vereb G, Zahler S, Wagner E, Muller R, Scita G, Vollmar AM (2012) The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1. Cancer Res 72(22):5976-5987. doi: 10.1158/0008-5472.CAN-12-17720008-5472.CAN-12-1772
16. Rojas JD, Sennoune SR, Maiti D, Bakunts K, Reuveni M, Sanka SC, Martinez GM, Seftor EA, Meininger CJ, Wu G, Wesson DE, Hendrix MJ, Martinez-Zaguilan R (2006) Vacuolar-type H+-ATPases at the plasma membrane regulate pH and cell migration in microvascular endothelial cells. Am J Physiol Heart Circ Physiol 291(3):H1147-H1157
17. Rojas JD, Sennoune SR, Maiti D, Martinez GM, Bakunts K, Wesson DE, Martinez-Zaguilan R (2004) Plasmalemmal V-H(+)-ATPases regulate intracellular pH in human lung microvascular endothelial cells. Biochem Biophys Res Commun 320(4):1123-1132. doi: 10.1016/j.bbrc.2004.06.068S0006291X04012355
18. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99(6):683-690
19. Koltermann A, Hartkorn A, Koch E, Furst R, Vollmar AM, Zahler S (2007) Ginkgo biloba extract EGb 761 increases endothelial nitric oxide production in vitro and in vivo. Cell MolLife Sci 64(13):1715-1722
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139(2):271-279
21. Rath S, Liebl J, Furst R, Ullrich A, Burkhart JL, Kazmaier U, Herrmann J, Muller R, Gunther M, Schreiner L, Wagner E, Vollmar AM, Zahler S (2012) Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives. Br J Pharmacol 167(5):1048-1061. doi: 10.1111/j1476-5381201202037x
22. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
23. Bowman EJ, Kendle R, Bowman BJ (2000) Disruption of vma-1, the gene encoding the catalytic subunit of the vacuolar H(+)-ATPase, causes severe morphological changes in Neurospora crassa. J Biol Chem 275(1):167-176
24. Robinson DG, Albrecht S, Moriysu Y (2004) The V-ATPase inhibitors concanamycin A and bafilomycin A lead to Golgi swelling in tobacco BY-2 cells. Protoplasma 224(3-4):255-260. doi: 10.1007/s00709-004-0070-6
25. Nakayama M, Berger P (2013) Coordination of VEGF receptor trafficking and signaling by coreceptors. Exp Cell Res. doi: 10.1016/j.yexcr.2013.03.008
26. Nakayama M, Nakayama A, van Lessen M, Yamamoto H, Hoffmann S, Drexler HC, Itoh N, Hirose T, Breier G, Vestweber D, Cooper JA, Ohno S, Kaibuchi K, Adams RH (2013) Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol 15(3):249-260. doi: 10.1038/ncb2679ncb2679
27. Niikura K, Takano M, Sawada M (2004) A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase. Br J Pharmacol 142(3):558-566
28. De Milito A, Fais S (2005) Proton pump inhibitors may reduce tumour resistance. Expert Opin Pharmacother 6(7):1049-1054
29. Torigoe T, Izumi H, Ishiguchi H, Uramoto H, Murakami T, Ise T, Yoshida Y, Tanabe M, Nomoto M, Itoh H, Kohno K (2002) Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents. J Biol Chem 277(39):36534-36543
30. Lu X, Qin W, Li J, Tan N, Pan D, Zhang H, Xie L, Yao G, Shu H, Yao M, Wan D, Gu J, Yang S (2005) The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 65(15):6843-6849. doi: 10.1158/0008-5472.CAN-04-3822
31. Rojas JD, Sennoune SR, Martinez GM, Bakunts K, Meininger CJ, Wu G, Wesson DE, Seftor EA, Hendrix MJ, Martinez-Zaguilan R (2004) Plasmalemmal vacuolar H+-ATPase is decreased in microvascular endothelial cells from a diabetic model. J Cell Physiol 201(2):190-200. doi: 10.1002/jcp20059
32. Hendrix A, Sormunen R, Westbroek W, Lambein K, Denys H, Sys G, Braems G, Van den Broecke R, Cocquyt V, Gespach C, Bracke M, De Wever O (2013) Vacuolar H+ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer 133(4):843-854. doi: 10.1002/ijc.28079
33. Lim JH, Park JW, Kim MS, Park SK, Johnson RS, Chun YS (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Mol Pharmacol 70(6):1856-1865. doi: 10.1124/mol.106.028076
34. Connolly JO, Simpson N, Hewlett L, Hall A (2002) Rac regulates endothelial morphogenesis and capillary assembly. Mol Biol Cell 13(7):2474-2485. doi: 10.1091/mbc.E02-01-0006
35. Ridley AJ (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol 11(12):471-477
36. Palamidessi A, Frittoli E, Garre M, Faretta M, Mione M, Testa I, Diaspro A, Lanzetti L, Scita G, Di Fiore PP (2008) Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 134(1):135-147
37. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7(5):359-371. doi: 10.1038/nrm1911
38. Shibuya M (2008) Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep 41(4):278-286
39. Shiojima I, Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90(12):1243-1250
40. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275(7):5096-5103
41. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247(2):495-504. doi: 10.1006/excr.1998.4359
42. Bruns AF, Bao L, Walker JH, Ponnambalam S (2009) VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis. Biochem Soc Trans 37(Pt 6):1193-1197. doi: 10.1042/BST0371193BST0371193
43. Mannell HK, Pircher J, Chaudhry DI, Alig SK, Koch EG, Mettler R, Pohl U, Krotz F (2012) ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression. Cardiovasc Res 93(1):111-119. doi: 10.1093/cvr/cvr265cvr265
44. Gridley T (2010) Notch signaling in the vasculature. Curr Top Dev Biol 92:277-309. doi: 10.1016/S0070-2153(10)92009-7S0070-2153(10)92009-7
45. Petzoldt AG, Gleixner EM, Fumagalli A, Vaccari T, Simons M (2013) Elevated expression of the V-ATPase C subunit triggers JNK-dependent cell invasion and overgrowth in a Drosophila epithelium. Dis Model Mech 6(3):689-700. doi: 10.1242/dmm010660dmm.010660
46. Vaccari T, Duchi S, Cortese K, Tacchetti C, Bilder D (2010) The vacuolar ATPase is required for physiological as well as pathological activation of the Notch receptor. Development 137(11):1825-1832. doi: 10.1242/dev.045484137/11/ 1825